» Articles » PMID: 8689683

Atm-deficient Mice: a Paradigm of Ataxia Telangiectasia

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1996 Jul 12
PMID 8689683
Citations 568
Authors
Affiliations
Soon will be listed here.
Abstract

A murine model of ataxia telangiectasia was created by disrupting the Atm locus via gene targeting. Mice homozygous for the disrupted Atm allele displayed growth retardation, neurologic dysfunction, male and female infertility secondary to the absence of mature gametes, defects in T lymphocyte maturation, and extreme sensitivity to gamma-irradiation. The majority of animals developed malignant thymic lymphomas between 2 and 4 months of age. Several chromosomal anomalies were detected in one of these tumors. Fibroblasts from these mice grew slowly and exhibited abnormal radiation-induced G1 checkpoint function. Atm-disrupted mice recapitulate the ataxia telangiectasia phenotype in humans, providing a mammalian model in which to study the pathophysiology of this pleiotropic disorder.

Citing Articles

A targetable OSGIN1 - AMPK - SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis.

Deng M, Tang F, Chang X, Zhang Y, Liu P, Ji X NPJ Precis Oncol. 2025; 9(1):15.

PMID: 39809873 PMC: 11733211. DOI: 10.1038/s41698-024-00791-8.


ATM in immunobiology: From lymphocyte development to cancer immunotherapy.

Lee J Transl Oncol. 2025; 52():102268.

PMID: 39752906 PMC: 11754496. DOI: 10.1016/j.tranon.2024.102268.


ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival.

An J, Hathcock K, Steinberg S, Choo-Wosoba H, Hodes R PLoS One. 2024; 19(12):e0312864.

PMID: 39637056 PMC: 11620668. DOI: 10.1371/journal.pone.0312864.


Generation and long-term culture of human cerebellar organoids from pluripotent stem cells.

Atamian A, Birtele M, Hosseini N, Quadrato G Nat Protoc. 2024; .

PMID: 39623220 DOI: 10.1038/s41596-024-01093-w.


Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628.

Garcia D, Rathi S, Connors M, Grams M, Vaubel R, Bakken K Mol Cancer Ther. 2024; 24(2):299-309.

PMID: 39559836 PMC: 11791477. DOI: 10.1158/1535-7163.MCT-24-0664.